BioSpace News Archive

Ludwig Enterprises, Inc. today announced the appointment of Scott Silverman as Chief Financial Officer (CFO).

MicroVention, Inc. is celebrating a decade of legacy innovation commemorating the anniversary of SOFIA™ and SOFIA™ Flow Plus Aspiration Catheters, with more than half a million worldwide procedures performed across 170 countries, and 30+ articles published globally since it was first introduced ten years ago.

ImmunityBio, Inc. ( NASDAQ: IBRX ), a clinical-stage immunotherapy company, announced today that the company will be participating in the 35th Annual Piper Sandler Healthcare Conference, which is taking place in New York City, November 28-30, 2023.

Autonomix Medical, Inc. (“Autonomix” or the “Company”) a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated, today announced the appointment of Christopher C. Capelli, M.D. to its Board of Directors.

ABVC BioPharma, Inc., a clinical-stage biopharmaceutical company developing therapeutic solutions in ophthalmology, CNS, and oncology/hematology, announced that it entered into a global licensing definitive agreement with AiBtl BioPharma Inc. for the Company’s CNS drugs with the indications of MDD and ADHD .

Hospital for Special Surgery, the world’s leading musculoskeletal health institution, has received support from Schmidt Futures to advance its research and development efforts in artificial intelligence and machine learning.

Probo Medical (“Probo”), a leading global provider of medical imaging equipment, parts, repair and service, announced the acquisition of Davis Medical Electronics, Inc. (“Davis Medical”).

The global red biotechnology market size is predicted to garner around USD 618.64 billion by 2032 and is expanding at a CAGR of 5.41% from 2023 to 2032.

Royal Philips and NYU Langone Health announced an 8-year strategic partnership valued up to USD 115 million and aimed at enhancing patient care through further innovation.

The US Food and Drug Administration (FDA) has granted over-the-counter marketing clearance for the ManaFlexx 2®, an Electrical Stimulation (EMS) device, from MANAMED®, LLC.